4//SEC Filing
MacDonald Sean Arthur 4
Accession 0001778981-19-000003
CIK 0001540159other
Filed
Jul 29, 8:00 PM ET
Accepted
Jul 30, 5:40 PM ET
Size
5.3 KB
Accession
0001778981-19-000003
Insider Transaction Report
Form 4
MacDonald Sean Arthur
Director
Transactions
- Award
Common Shares
2019-07-26+786→ 14,369 total
Footnotes (2)
- [F1]Represents additional common shares of Edesa Biotech, Inc. (formerly known as Stellar Biotechnologies, Inc.) (the "Issuer") issued pursuant to the post-closing adjustment contemplated by that certain Share Exchange Agreement, dated as of March 7, 2019, by and among the Issuer, Edesa Biotech, Inc. ("Edesa"), and the shareholders of Edesa. The closing of the share exchange transaction contemplated by the Share Exchange Agreement occurred on June 7, 2019, at which time the Issuer acquired all the outstanding capital shares of Edesa from the Edesa shareholders.
- [F2]All share numbers reflect the 1-for-6 reverse split of the Issuer's common shares which occurred on June 7, 2019.
Documents
Issuer
Edesa Biotech, Inc.
CIK 0001540159
Entity typeother
Related Parties
1- filerCIK 0001778981
Filing Metadata
- Form type
- 4
- Filed
- Jul 29, 8:00 PM ET
- Accepted
- Jul 30, 5:40 PM ET
- Size
- 5.3 KB